Zobrazeno 1 - 10
of 328
pro vyhledávání: '"Guy, Jerusalem"'
Autor:
Louise Baussard, Marie Ernst, Anh Diep, Guy Jerusalem, Audrey Vanhaudenhuyse, Nolwenn Marie, Isabelle Bragard, Marie‐Elisabeth Faymonville, Olivia Gosseries, Charlotte Grégoire
Publikováno v:
Cancer Medicine, Vol 13, Iss 19, Pp n/a-n/a (2024)
ABSTRACT Background Understanding cancer symptom cluster through network analyses is a new approach in oncology, revealing interconnected and influential relationships among reported symptoms. We aimed to assess these relationships using network anal
Externí odkaz:
https://doaj.org/article/61aa77c900e843ba97566c63e5ce96a8
Autor:
Charlotte Grégoire, Louise Baussard, Marie Ernst, Anh Diep, Marie-Elisabeth Faymonville, Martine Devos, Guy Jerusalem, Audrey Vanhaudenhuyse
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background A psychoneurological symptom cluster composed of cancer-related fatigue, emotional distress, sleep difficulties, and pain is very common among patients with cancer. Cognitive difficulties are also frequently associated with this c
Externí odkaz:
https://doaj.org/article/33aa485a94b84c3db4cbd1e439614b21
Autor:
Guy Jerusalem, Aleix Prat, Roberto Salgado, Mattea Reinisch, Cristina Saura, Manuel Ruiz-Borrego, Petros Nikolinakos, Felipe Ades, Jeiry Filian, Ning Huang, Antonella Mazzei-Abba, Sara M. Tolaney
Publikováno v:
Breast, Vol 72, Iss , Pp 103580- (2023)
Background: Preclinical data suggest synergistic activity with the combination of programmed death-1 and cyclin-dependent kinase 4/6 blockade in oestrogen receptor-positive/human epidermal growth factor 2-negative (ER+/HER2–) breast cancer. The non
Externí odkaz:
https://doaj.org/article/0fa5c73c7ab04a5990f87bbac59a8a3e
Autor:
Nan Niu, Fang Qiu, Qianshi Xu, Guijin He, Xi Gu, Wenbin Guo, Dianlong Zhang, Zhigao Li, Yi Zhao, Yong Li, Ke Li, Hao Zhang, Peili Zhang, Yuanxi Huang, Gangling Zhang, Hongbin Han, Zhengang Cai, Pengfei Li, Hong Xu, Guanglei Chen, Jinqi Xue, Xiaofan Jiang, Alireza Hamidian Jahromi, Jinshi Li, Yu Zhao, Eduardo de Faria Castro Fleury, Shiwen Huo, Huajun Li, Guy Jerusalem, Domenico Tripodi, Tong Liu, Xinyu Zheng, Caigang Liu
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-9 (2022)
Neoadjuvant therapy is recommended for patients with locally advanced breast cancer. Here the authors report the results of a phase 2 clinical trial of oral neoadjuvant therapy with pyrotinib (pan-HER tyrosine kinase inhibitor), letrozole (aromatase
Externí odkaz:
https://doaj.org/article/1d9c37ba0fbf4148af08531c29508fb7
Autor:
Cindy Kenis, Lore Decoster, Johan Flamaing, Philip R. Debruyne, Inge De Groof, Christian Focan, Frank Cornélis, Vincent Verschaeve, Christian Bachmann, Dominique Bron, Heidi Van den Bulck, Dirk Schrijvers, Christine Langenaeken, Pol Specenier, Guy Jerusalem, Jean-Philippe Praet, Jessie De Cock, Jean-Pierre Lobelle, Hans Wildiers, Koen Milisen
Publikováno v:
BMC Geriatrics, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Falls and fall-related injuries are a major public health problem. Data on falls in older persons with cancer is limited and robust data on falls within those with a frailty profile are missing. The aim of this study is to investi
Externí odkaz:
https://doaj.org/article/bf52381393b7483d81bf534bf0fcbe9e
Autor:
Hope S. Rugo, Peter Kabos, J. Thad Beck, Guy Jerusalem, Hans Wildiers, Elena Sevillano, Luis Paz-Ares, Michael J. Chisamore, Sonya C. Chapman, Anwar M. Hossain, Yanyun Chen, Sara M. Tolaney
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-8 (2022)
Abstract This nonrandomized, open-label, multi-cohort Phase 1b study (NCT02779751) investigated the safety and efficacy of abemaciclib plus pembrolizumab with/without anastrozole in patients with hormone receptor-positive (HR+), human epidermal growt
Externí odkaz:
https://doaj.org/article/273e69685df94ce99e4481cd2a74cdd4
Autor:
Concetta Elisa Onesti, Marco Tagliamento, Giuseppe Curigliano, Nadia Harbeck, Rupert Bartsch, Hans Wildiers, Vivianne Tjan-Heijnen, Miguel Martin, Sylvie Rottey, Daniele Generali, Mario Campone, Massimo Cristofanilli, Lajos Pusztai, Marc Peeters, Guy Berchem, Javier Cortes, Thomas Ruhstaller, Eva Ciruelos, Hope S. Rugo, Guy Jerusalem
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 162-172 (2021)
PURPOSEThe COVID-19 pandemic has affected healthcare systems globally, leading to reorganization of medical activities. We performed an international survey aimed to investigate the medium- and long-term impact on oncology units.MATERIALS AND METHODS
Externí odkaz:
https://doaj.org/article/bd29c35c2a11451b828253e82753a9a8
Autor:
Concetta Elisa Onesti, Hélène Schroeder, Andrée Rorive, Brieuc Sautois, Marie Lecocq, Marie Goffin, Elodie Gonne, Astrid Collinge, Laurence Nicolaers, Odile Wéra, Amandine Catot, Catherine Loly, Astrid Paulus, Anne Sibille, Laurence Lousberg, Florence Troisfontaine, Joëlle Collignon, Christine Gennigens, Pierre Frères, Marc Polus, Bernard Duysinx, Frédérique Vaillant, Nathalie Marchal, Aurélie Poncin, Guy Jerusalem
Publikováno v:
Cancer Reports, Vol 5, Iss 10, Pp n/a-n/a (2022)
Abstract Background The spread of the COVID‐19 pandemic has led to a rapid reorganization in all human and hospital activities, with impact on cancer patients. Aim An analysis of cancer patients fears, and awareness of COVID‐19 has been done in t
Externí odkaz:
https://doaj.org/article/4801fa676c274876a0c7ba8b5957c880
Autor:
Jeanne P. Uyisenga, Ahmed Debit, Christophe Poulet, Pierre Frères, Aurélie Poncin, Jérôme Thiry, Leon Mutesa, Guy Jerusalem, Vincent Bours, Claire Josse
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Circulating microRNAs are non-invasive biomarkers that can be used for breast cancer diagnosis. However, differences in cancer tissue microRNA expression are observed in populations with different genetic/environmental backgrounds. This work
Externí odkaz:
https://doaj.org/article/d916c08b576f43a2930a6c35039f5062
Autor:
Peter Schmid, Marie-Paule Sablin, Jonas Bergh, Seock-Ah Im, Yen-Shen Lu, Noelia Martínez, Patrick Neven, Keun Seok Lee, Serafín Morales, J. Alejandro Pérez-Fidalgo, Douglas Adamson, Anthony Gonçalves, Aleix Prat, Guy Jerusalem, Laura Schlieker, Rosa-Maria Espadero, Thomas Bogenrieder, Dennis Chin-Lun Huang, John Crown, Javier Cortés
Publikováno v:
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)
Abstract Background Xentuzumab—a humanised IgG1 monoclonal antibody—binds IGF-1 and IGF-2, inhibiting their growth-promoting signalling and suppressing AKT activation by everolimus. This phase Ib/II exploratory trial evaluated xentuzumab plus eve
Externí odkaz:
https://doaj.org/article/1117dc67dd994a8f8f4c31719c73a41f